Molecular biology of exocrine pancreatic cancer

J. L. Soto, V. M. Barberá, Alfredo Carrato

Research output: Contribution to journalScientific review

1 Scopus citations

Abstract

Exocrine pancreatic cancer remains as one of the deadliest cancers. Conventional treatments have little impact on disease outcome. Molecular research on both sporadic and inherited forms of pancreatic cancer, has yielded important advances in the understanding of the disease at the molecular level. The availability of in vitro and in vivo models allows the design of pathophysiologic studies in this tumour. As a consequence, new molecular therapeutic targets have been identified. Gene therapy, antiangiogenic treatments, immunotherapy, and signal-transduction inhibition are in preclinical development. This review presents an update of molecular biology aspects and their potential applications in the daily clinical practice. Copyright © 2005 Aran Ediciones, S. L.
Original languageAmerican English
Pages (from-to)12-26
Number of pages15
JournalRevisiones en Cancer
StatePublished - 29 Jul 2005
Externally publishedYes

Fingerprint Dive into the research topics of 'Molecular biology of exocrine pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this

    Soto, J. L., Barberá, V. M., & Carrato, A. (2005). Molecular biology of exocrine pancreatic cancer. Revisiones en Cancer, 12-26.